![Habib Dable](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Habib Dable
Direktör/Styrelseledamot på
PEPGEN INC.
Förmögenhet: - $ per 2026-08-31
Profil
Habib Joseph Dable currently works at SpyGlass Pharma, Inc., as Director from 2026, PepGen Inc., as Independent Non-Executive Director from 2022, Relay Therapeutics, Inc., as Independent Director from 2025, Tyra Biosciences, Inc., as Independent Director from 2026, and RA Ventures, Inc., as Partner.
Mr. Dable also formerly worked at Acceleron Pharma, Inc., as President, Chief Executive Officer & Director from 2016 to 2021, Jade Biosciences, Inc., as Chairman from 2024 to 2025, Biotechnology Innovation Organization, as Director from 2016 to 2017, Blueprint Medicines Corp., as Independent Director from 2022 to 2025, Albireo Pharma, Inc., as Independent Director from 2022 to 2023, Millendo Therapeutics, Inc., as Independent Director from 2018 to 2021, Day One Biopharmaceuticals, Inc., as Independent Director from 2024 to 2026, Bayer AG, as President-US Pharmaceuticals from 2015 to 2016, and Bayer HealthCare Pharmaceuticals, Inc., as EVP & Global Head- Specialty Medicine from 2013 to 2016.
Mr. Dable received his undergraduate degree and Masters Business Admin degree from the University of New Brunswick.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-09 | 0 ( -.--% ) | - $ | 2026-08-31 | |
TYRA BIOSCIENCE, INC -.--% | 2026-04-16 | 0 ( -.--% ) | - $ | 2026-08-31 |
PEPGEN INC. -.--% | 2026-06-18 | 0 ( -.--% ) | - $ | 2026-08-31 |
| 2026-02-05 | 0 ( -.--% ) | - $ | 2026-08-31 |
Senaste nyheterna om Habib Dable
Aktiva positioner av Habib Dable
| Företag | Position | Start |
|---|---|---|
| PEPGEN INC. | Direktör/Styrelseledamot | 2022-09-22 |
| RELAY THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2025-11-04 |
| SPYGLASS PHARMA, INC. | Direktör/Styrelseledamot | 2026-02-05 |
| TYRA BIOSCIENCES, INC. | Direktör/Styrelseledamot | 2026-04-16 |
RA Ventures, Inc.
 RA Ventures, Inc. Real Estate DevelopmentFinance RA Ventures, Inc., operating as RA Capital Management, is a multi-stage investment and company-building firm focused on healthcare, life sciences, and climate and sustainability technologies. The private company is based in MN. The firm invests in and supports companies developing drugs, medical devices, diagnostics, research tools, and environmental solutions aimed at improving human and planetary health. RA Capital employs an evidence-based, data-driven investment approach supported by internal research teams, and offers strategic support including incubation, American company creation, financing, technology transfer, and executive recruitment. RA Capital also supports social responsibility initiatives such as affordable drug access and sustainable environmental solutions. The firm collaborates with academia and entrepreneurs to translate scientific discoveries into products, provides flexible models for founder involvement, and fosters community engagement and knowledge sharing through online platforms. | Företagsledare/Principal | - |
Tidigare kända positioner av Habib Dable
| Företag | Position | Slut |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Direktör/Styrelseledamot | 2026-04-23 |
| BLUEPRINT MEDICINES CORPORATION | Direktör/Styrelseledamot | 2025-07-17 |
| JADE BIOSCIENCES, INC. | Ordförande | 2025-04-28 |
| ALBIREO PHARMA, INC. | Direktör/Styrelseledamot | 2023-03-02 |
| ░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Habib Dables utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
80
Första gradens relationer
15
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 15 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
University of New Brunswick
 University of New Brunswick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
RA Ventures, Inc.
RA Ventures, Inc. Real Estate DevelopmentFinance RA Ventures, Inc., operating as RA Capital Management, is a multi-stage investment and company-building firm focused on healthcare, life sciences, and climate and sustainability technologies. The private company is based in MN. The firm invests in and supports companies developing drugs, medical devices, diagnostics, research tools, and environmental solutions aimed at improving human and planetary health. RA Capital employs an evidence-based, data-driven investment approach supported by internal research teams, and offers strategic support including incubation, American company creation, financing, technology transfer, and executive recruitment. RA Capital also supports social responsibility initiatives such as affordable drug access and sustainable environmental solutions. The firm collaborates with academia and entrepreneurs to translate scientific discoveries into products, provides flexible models for founder involvement, and fosters community engagement and knowledge sharing through online platforms. | Finance |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Relay Therapeutics, Inc.
 Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Millendo Therapeutics, Inc.
 Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Tyra Biosciences, Inc.
 Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
Aerovate Therapeutics, Inc.
 Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
PepGen Inc.
 PepGen Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company which develops oligonucleotide therapeutics for treatment of severe neuromuscular and neurologic diseases | Health Technology |
Day One Biopharmaceuticals, Inc.
 Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
SpyGlass Pharma Inc
 SpyGlass Pharma Inc BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops IOL-mounted drug delivery platform for glaucoma patients | Health Technology |
